Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

One of UK's biggest 'Breaking Bad' labs flooded streets with drugs worth £10m a MONTH

John Keet invested profits from a career dealing cocaine, cannabis and amphetamines into building and managing the lab in Henley-in-Arden, a quaint market town in Warwickshire

Daily Mirror

Staff shortages force pharmacies to close for 100,000 hours in a year amid plans to give them more work

Exclusive: It comes as experts warn plans to move work from GPs to pharmacies will have ‘marginal’ impact on GP crisis

The Independent UK

This Botox Rival Has Investors Frowning After Missing Q1 Earnings Estimates. The Stock Reversed Course After The Report.

Revance Therapeutics, a biotech stock, reported earnings late Tuesday. Shares are tanking after the numbers surprised investors.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Growth Stocks to Buy Now

As a slowdown in monetary policy tightening is paving its way, the possibility of a soft landing still stands. Therefore, it could be an ideal opportunity for investors to load up on some fundamentally sound growth stocks, Novartis (NVS), Daimler Truck Holding (DTRUY), and CPI Aerostructures (CVU). Read on….

StockNews.com

2 Most Promising Biotech Stocks to Buy

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT Biopharma (PNT) could be worth buying now. Read on.

StockNews.com

“I’m 78 and my youthful skin is all down to this £10 Boots anti-ageing serum”

The No7 anti-ageing serum is usually £34.95 and has been reduced to £10 as part of Boots' weekly £10 Tuesday offers

Chronicle Live

Pharmacies in England to offer prescriptions for seven conditions amid surgery crisis

Proposal is designed to free up 15m GP appointments over the next two years

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

No. 1 Undervalued Stock in May

Leading healthcare company McKesson’s (MCK) stock looks undervalued at its current price and could be an excellent pick for value investors. Let’s look at some of MCK’s key metrics.

StockNews.com

Roadside drug testing could have gone ahead on time - Police Association

The Police Association says alternative policy could have been pushed through in order to enable roadside drug testing on time.

Newsroom.co.nz

Warning of more pharmacy closures ‘unless Government provides urgent funding’

Government proposals to improve access to primary care are expected on Tuesday.

The Independent UK

The Bottom of the Barrel: The Worst Drug Store Stock for Investors

MedAvail Holdings’ (MDVL) net loss widened by nearly 9% in fiscal 2022. The company has been taking some measures to achieve profitability, but it still looks far away. Amid this backdrop, investors could consider avoiding the stock. Read more….

StockNews.com

Protagonist, A Top 1% Biotech, Briefly Breaks Out On Psoriasis Enthusiasm

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.

Investors Business Daily

FDA weighing 1st over-the-counter birth control pill

U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription

The Independent UK

Shield Therapeutics shareholders told to reject £46.1m takeover offer

One of the firm's long term shareholders has tabled an offer

Birmingham Post

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Explosion rips roof off pharmaceutical plant; worker missing

Officials say an explosion at a pharmaceutical plant in Massachusetts left one worker missing and sent four people to the hospital as a precaution

Birmingham Post

Drug testing venture Cansford Laboratories acquired by Phenna Group

Lexington Corporate Finance advised the shareholders of Cansford on the sale

Birmingham Post

Certus Biomedical relocates to meet growing demand with plans to double workforce

The Cornwall-based medical equipment service and supply company hopes to double its team in the next two years

AFP

US issues world's first approval of RSV vaccine

Washington (AFP) - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

AZN Stock Today: This Options Trade Boosts AstraZeneca Stock Yield To 21% Annualized

Selling the call option generates an income of 2.7% in just over one month.

Tom’s Hardware

AMD Says Delayed 7040HS 'Phoenix' Laptop CPUs Are Now Shipping to OEMs

AMD says that it has made its own self-imposed deadline to ship its Ryzen 7040HS laptop processors, also known as the "Phoenix" series, to OEMs.

Investors Business Daily

Incyte Stock Crumbles As Seasonality Hammers Away At First-Quarter Sales

Incyte stock plummeted Tuesday as seasonality hacked at first-quarter revenue and profit with notable sales misses from Jakafi and Opzelura.

AFP

Nearly 300 arrested in US-Europe dark web drug bust

The Hague (AFP) - A multi-continental crackdown has halted a major "dark web" drugs marketplace, with international police arresting 288 suspects and recovering more than 50 million euros ($54.8 million) in cash and virtual currency, Europol said Tuesday.

Wales Online

High Court hearing to begin over hormone pregnancy test blamed for birth defects

More than 200 people are launching a legal case after claiming to be caused harm by the drug Primodos, which was given to women to test if they were pregnant from the 1950s until the late 1970s

The Texas Tribune

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

Investors Business Daily

Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge

Sleep-apnea device maker ResMed broke out after earnings, continuing its accelerating growth pace.

1 … 36 37 38 39

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the London Stock Exchange

106 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.